Kevin Gorman Neurocrine Biosciences CEO Rating

Neurocrine Biosciences CEO Kevin Gorman Bio

Dr. Kevin C. Gorman, Ph.D., is Chief Executive Officer of Neurocrine Biosciences, Inc. Dr. Gorman served as Executive Vice President of Neurocrine Biosciences, Inc. since January 2006 until January 2008 and also served as its Chief Operating Officer since September 2006 until January 2008 and President from January 2008 to January 09, 2017. He served as Senior Vice President for Business Development of Neurocrine Biosciences, Inc. from January 2006 to September 2006 and its Chief Business Officer since January 2006. He has been employed with Neurocrine Biosciences, Inc. since 1993. From 1990 to 1993, Dr. Gorman was a Principal of Avalon Medical Partners, LP where he was responsible for the early stage founding of Avalon Medical Partners, LP and several other biotechnology companies such as Onyx Pharmaceuticals, Metra Biosystems, IDUN and ARIAD Pharmaceuticals. He has been a Director of Neurocrine Biosciences Inc. since January 2008 and Xencor, Inc. since April 14, 2017. Dr. Gorman received his Ph.D. degree in Immunology and M.B.A. in Finance from the University of California, Los Angeles and did further Post-Doctoral Training at The Rockefeller University.

Neurocrine Biosciences CEO Kevin Gorman At a Glance

The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Neurocrine Biosciences.

Based on 6 ratings, Kevin Gorman ranks right above Biogen's CEO, Michel Vounatsos.

Overall, the CEO score has remained stable over the last 90 days.